| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 11/06/2018 | 16:01 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 06/06/2018 | 17:04 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/06/2018 | 23:25 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 23/05/2018 | 12:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 17/05/2018 | 17:49 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 15/05/2018 | 18:51 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 15/05/2018 | 18:44 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 15/05/2018 | 18:34 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 15/05/2018 | 18:32 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 15/05/2018 | 18:21 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 15/05/2018 | 15:04 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 15/05/2018 | 13:28 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 15/05/2018 | 13:04 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/05/2018 | 23:10 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 03/05/2018 | 22:01 | GlobeNewswire Inc. | AveXis Reports First Quarter 2018 Financial and Operating Results | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 02/05/2018 | 15:27 | GlobeNewswire Inc. | AveXis Provides Update on Proposed Acquisition by Novartis AG | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 30/04/2018 | 23:26 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 25/04/2018 | 14:00 | GlobeNewswire Inc. | AveXis Announces First Patient Dosed in Phase 3 Trial of AVXS-101 in Pre-Symptomatic SMA Types 1, 2 and 3 | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 24/04/2018 | 22:01 | GlobeNewswire Inc. | AveXis Presents Initial Data from Pivotal U.S. Trial for SMA Type 1 and 24-Month Follow-Up Data from Phase 1 Trial of AVXS-10... | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 20/04/2018 | 17:51 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 19/04/2018 | 14:00 | GlobeNewswire Inc. | AveXis to Present AVXS-101 Data at the Annual Meeting of the American Academy of Neurology | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 17/04/2018 | 22:29 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 17/04/2018 | 22:28 | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 11/04/2018 | 23:41 | PR Newswire (US) | WEISSLAW LLP Investigates AveXis Inc. Acquisition | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 10/04/2018 | 22:49 | Edgar (US Regulatory) | Written Communication Relating to an Issuer or Third Party (sc To-c) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 10/04/2018 | 09:02 | Dow Jones News | Novartis Deal to Help Drug Pipeline -- WSJ | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 10/04/2018 | 09:02 | Dow Jones News | What's News: Business & Finance -- WSJ | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 09/04/2018 | 23:28 | Edgar (US Regulatory) | Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 09/04/2018 | 18:59 | Dow Jones News | Gene-Therapy Stocks Get Boost as Analysts Speculate Novartis' Next Target -- Market Mover | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 09/04/2018 | 18:00 | Dow Jones News | Novartis Buying AveXis for $8.7 Billion -- Deal Digest | NASDAQ:AVXS | Avexis, Inc. (delisted) |